VivoPharm Overview
- Founded
-
2003

- Status
-
Acquired/Merged
- Employees
-
35

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
- Investments
-
1
VivoPharm General Information
Description
Provider of proprietary preclinical oncology and immuno-oncology services intended to offer integrated service in different disease areas to the biotechnology and pharmaceutical industries. The company specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug (IND) filing, thereby enabling its clients to get treated in a better way in different disease areas.
Contact Information
Website
www.vivopharm.com.au
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
- Level 3, 240 Plenty Road, Bundoora
- Suite S29
- Melbourne, Victoria 3083
- Australia
+61 (03) 0000 0000
VivoPharm Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
VivoPharm Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of proprietary preclinical oncology and immuno-oncology services intended to offer integrated service in differ
Other Pharmaceuticals and Biotechnology
Melbourne, Australia
35
As of 2022
00.00
0.000
0000-00-00
000000000000
VivoPharm Competitors (12)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Medelis | Private Equity-Backed | Nashville, TN | 00 | 000000000000 | ||
000 | Formerly PE-Backed | Warsaw, Poland | 000 | 00000000000 | ||
0000000 000000000 | Formerly VC-backed | Cambridge, United Kingdom | 000 | 00000 | 000000&0 | 00000 |
000 000 | Corporation | Zug, Switzerland | ||||
0000000 | Private Equity-Backed | Ann Arbor, MI | 00000 | 0000000 0000 |
VivoPharm Patents
VivoPharm Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20050214220-A1 | Developing orthotopic animal models; quickly and reliably testing antitumor agent efficacy | Inactive | 24-Mar-2004 | 00000000000 | |
AU-2004901532-A0 | Tumour model | Inactive | 24-Mar-2004 | ||
AU-2005201291-A1 | Tumour model | Inactive | 24-Mar-2004 |
VivoPharm Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sabine Brandt | Co-Founder & Executive Finance & HR Manager | ||
Melanie Keller | Division Head, Europe | ||
Chris Holding | Division Head of Efficacy Testing |
VivoPharm Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
0000000 000000 | VivoPharm | Board Member | 000 0000 |
000 000000 00.0 | Self | Chairman | 000 0000 |
0000 000000 00.0 | VivoPharm | Co-Founder & President, Discovery and Early Development | 000 0000 |
VivoPharm Signals
VivoPharm Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
VivoPharm Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 0000 000 | 11-Apr-2012 | 0000000000 | Laboratory Services (Healthcare) |